title: Neurosarcoidosis presenting as longitudinally extensive transverse myelitis.
abstract: Neurosarcoidosis is an uncommon clinical entity, even in patients with systemic sarcoidosis. Its presentation is widely varied but longitudinally extensive transverse myelitis secondary to neurosarcoidosis has only rarely been described. We report the case of a patient with pulmonary sarcoidosis and congenital immunosuppression who developed longitudinally extensive transverse myelitis secondary to neurosarcoidosis following splenectomy. Diagnosis was based on history, inflammatory changes on MRI, and cerebrospinal fluid findings. Standard therapy with intravenous steroids was unsuccessful. Only more novel treatment with Infliximab allowed improvement.
authors.affiliation: Department of Neurology, Vanderbilt Medical Center, A-0118 Medical Center North 1161 21st Avenue South, Nashville, Tennessee 37212, USA. rachel.dolhun@vanderbilt.edu
authors.forename: Rachel
authors.initials: R
authors.lastname: Dolhun
authors.forename: S
authors.initials: S
authors.lastname: Sriram
mesh_terms: D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D002493:Central Nervous System Diseases / Q000150:complications*; D006801:Humans; D000069285:Infliximab; D008279:Magnetic Resonance Imaging / Q000379:methods; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D009188:Myelitis, Transverse / Q000150:complications* / Q000188:drug therapy / Q000473:pathology*; D017565:Sarcoidosis, Pulmonary / Q000150:complications*
chemical_list: D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D000069285:Infliximab; D008775:Methylprednisolone